Literature DB >> 25865621

G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy.

Nozomi Hayashiji1, Shinsuke Yuasa1, Yuko Miyagoe-Suzuki2, Mie Hara1, Naoki Ito2, Hisayuki Hashimoto1, Dai Kusumoto1, Tomohisa Seki1, Shugo Tohyama1, Masaki Kodaira1, Akira Kunitomi1, Shin Kashimura1, Makoto Takei1, Yuki Saito1, Shinichiro Okata1, Toru Egashira1, Jin Endo1, Toshikuni Sasaoka3, Shin'ichi Takeda2, Keiichi Fukuda1.   

Abstract

Duchenne muscular dystrophy (DMD) is a chronic and life-threatening disease that is initially supported by muscle regeneration but eventually shows satellite cell exhaustion and muscular dysfunction. The life-long maintenance of skeletal muscle homoeostasis requires the satellite stem cell pool to be preserved. Asymmetric cell division plays a pivotal role in the maintenance of the satellite cell pool. Here we show that granulocyte colony-stimulating factor receptor (G-CSFR) is asymmetrically expressed in activated satellite cells. G-CSF positively affects the satellite cell population during multiple stages of differentiation in ex vivo cultured fibres. G-CSF could be important in developing an effective therapy for DMD based on its potential to modulate the supply of multiple stages of regenerated myocytes. This study shows that the G-CSF-G-CSFR axis is fundamentally important for long-term muscle regeneration, functional maintenance and lifespan extension in mouse models of DMD with varying severities.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25865621     DOI: 10.1038/ncomms7745

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  26 in total

Review 1.  Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials.

Authors:  Yuko Shimizu-Motohashi; Shouta Miyatake; Hirofumi Komaki; Shin'ichi Takeda; Yoshitsugu Aoki
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Sepsis Increases Muscle Proteolysis in Severely Burned Adults, but Does not Impact Whole-Body Lipid or Carbohydrate Kinetics.

Authors:  Andrew Murton; Fredrick J Bohanon; John O Ogunbileje; Karel D Capek; Ellen A Tran; Tony Chao; Labros S Sidossis; Craig Porter; David N Herndon
Journal:  Shock       Date:  2019-09       Impact factor: 3.454

3.  Actions of colony-stimulating factor 3 on the maturing oocyte and developing embryo in cattle.

Authors:  Elizabeth A Jannaman; Yao Xiao; Peter J Hansen
Journal:  J Anim Sci       Date:  2020-04-01       Impact factor: 3.159

4.  Muscle-secreted granulocyte colony-stimulating factor functions as metabolic niche factor ameliorating loss of muscle stem cells in aged mice.

Authors:  Hu Li; Qian Chen; Changyin Li; Ran Zhong; Yixia Zhao; Qianying Zhang; Weimin Tong; Dahai Zhu; Yong Zhang
Journal:  EMBO J       Date:  2019-11-18       Impact factor: 11.598

Review 5.  Moving towards successful exon-skipping therapy for Duchenne muscular dystrophy.

Authors:  Akinori Nakamura
Journal:  J Hum Genet       Date:  2017-06-01       Impact factor: 3.172

6.  COUP-TFII regulates satellite cell function and muscular dystrophy.

Authors:  Xin Xie; Sophia Y Tsai; Ming-Jer Tsai
Journal:  J Clin Invest       Date:  2016-09-12       Impact factor: 14.808

7.  A destabilised metabolic niche provokes loss of a subpopulation of aged muscle stem cells.

Authors:  Brendan Evano; Shahragim Tajbakhsh
Journal:  EMBO J       Date:  2019-12-04       Impact factor: 11.598

Review 8.  Current and Emerging Therapies for Duchenne Muscular Dystrophy.

Authors:  Megan Crone; Jean K Mah
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

Review 9.  Parallels between wound healing, epimorphic regeneration and solid tumors.

Authors:  Alan Y Wong; Jessica L Whited
Journal:  Development       Date:  2020-01-02       Impact factor: 6.868

Review 10.  Orienting Muscle Stem Cells for Regeneration in Homeostasis, Aging, and Disease.

Authors:  Peter Feige; Caroline E Brun; Morten Ritso; Michael A Rudnicki
Journal:  Cell Stem Cell       Date:  2018-11-01       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.